Noven Pharmaceuticals Tech Stack

Specialty pharma with FDA-approved transdermal manufacturing and U.S. prescription drug portfolio

Pharmaceutical Manufacturing Miami, Florida 201–500 employees Founded 1987 Privately Held

Noven is a specialty pharmaceutical company focused on transdermal drug delivery, operating FDA-approved and DEA-licensed manufacturing facilities in Miami with capacity for hundreds of millions of patches annually. The hiring mix—skewed toward manufacturing, regulatory, and sales roles—reflects a company scaling production and U.S. market reach as a wholly-owned subsidiary of Hisamitsu Pharmaceutical. Active projects in territory alignment, HCP segmentation, and sales reporting, paired with pain points around batch record accuracy and sales data quality, suggest operational friction between manufacturing rigor and commercial execution.

Tech Stack 12 technologies

Core StackSalesforce Power BI Tableau JD Edwards IQVIA SQL Excel PowerPoint WinNonlin HPLC GCP Microsoft Office

What Noven Pharmaceuticals Is Building

◆Challenges

Ensuring batch record accuracy
Compliance with fda and cgmp
Reducing documentation errors
Improving efficiency in sales reporting
Data quality in sales reporting
Managing cross-language communication

▲Active Projects

Monthly product release quality metrics reporting
Territory alignment
Hcp segmentation
Incentive compensation analysis
Budget process for the office of the ceo
Competitive data research
Precedent analysis
Regulatory environment monitoring

Hiring Activity

Accelerating8 roles · 6 in 30d

Department

Manufacturing

Executive

Healthcare

Regulatory

Research

Sales

Seniority

Mid

Intern

Junior

Senior

Company intelligence

Find more companies like Noven Pharmaceuticals by tech stack, pain points and active projects

Get started free

About Noven Pharmaceuticals

Noven Pharmaceuticals develops and manufactures prescription pharmaceutical products with deep expertise in transdermal delivery systems. The company operates state-of-the-art facilities in Miami, Florida and Jersey City, New Jersey, serving specialty and women's health markets. As a subsidiary of Hisamitsu Pharmaceutical—the world's largest transdermal patch manufacturer—Noven functions as the parent company's growth platform for U.S. prescription drugs. The organization spans research, development, manufacturing, regulatory, and sales functions across roughly 300 employees. Production capacity reaches several hundred million patches per year, with DEA licensing for controlled-substance manufacturing.

HeadquartersMiami, Florida

Company Size201–500 employees

Founded1987

Hiring MarketsUnited States

Frequently Asked Questions

What is Noven Pharmaceuticals' manufacturing capability?

Noven operates FDA-approved and DEA-licensed transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches annually. The facilities support both standard pharmaceuticals and controlled-substance production.

What does Noven Pharmaceuticals specialize in?

Noven specializes in transdermal drug delivery for prescription pharmaceuticals, with particular focus on women's health products. The company develops, manufactures, and markets formulations delivered via transdermal patches.